Assessment of the degree of adherence of medical laboratories to KDIGO 2012 guideline for evaluation and management of CKD in Czechia and Slovakia.


Journal

Biochemia medica
ISSN: 1846-7482
Titre abrégé: Biochem Med (Zagreb)
Pays: Croatia
ID NLM: 9610305

Informations de publication

Date de publication:
15 Oct 2019
Historique:
received: 15 02 2019
accepted: 17 06 2019
entrez: 6 8 2019
pubmed: 6 8 2019
medline: 14 8 2019
Statut: ppublish

Résumé

The aim of the study is to assess the degree of adherence of medical laboratories to Kidney Disease Improving Global Outcomes (KDIGO) 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (CKD) in laboratory practice in Czechia and Slovakia. An electronic questionnaire on adherence to KDIGO 2012 guideline was designed by an external quality assessment (EQA) provider SEKK spol. s.r.o. The questionnaire was placed and distributed through website to all medical biochemistry laboratories in Czechia and Slovakia (N = 396). A total of 212 out of 396 laboratories responded to the questions, though some laboratories only answered some questions, those applicable to their practice. A total of 48 out of 212 laboratories adopted the KDIGO 2012 guideline in full extent. The metrological traceability of creatinine measurement to standard reference material of SRM 967 was declared by 180 out of 210 laboratories (two of the responding laboratories did not measure creatinine). Thirty laboratories are not well educated on traceability of creatinine measurement and seven laboratories do not calculate estimated glomerular filtration rate (eGFR). Both urinary albumin concentration and albumin to creatinine ratio are reported by 144 out of 175 laboratories (37 of the responding laboratories did not measure urinary albumin). Majority of laboratories in Czechia and Slovakia adopted some parts of the KDIGO 2012 guideline in their practice, but only 23% of the laboratories apply them completely. Thus, further education and action should be conducted to improve its implementation.

Identifiants

pubmed: 31379462
doi: 10.11613/BM.2019.030704
pii: bm-29-3-030704
pmc: PMC6610673
doi:

Substances chimiques

Creatinine AYI8EX34EU

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

030704

Commentaires et corrections

Type : ErratumIn

Déclaration de conflit d'intérêts

Potential conflict of interest: None declared.

Références

Ann Intern Med. 1999 Mar 16;130(6):461-70
pubmed: 10075613
Clin Chem. 2007 Sep;53(9):1694-9
pubmed: 17660272
Scand J Clin Lab Invest. 2007;67(7):678-95
pubmed: 17852799
Am J Epidemiol. 2008 May 15;167(10):1226-34
pubmed: 18385206
Clin Chem Lab Med. 2010 Nov;48(11):1619-21
pubmed: 21034257
BMC Nephrol. 2012 Oct 08;13:133
pubmed: 23043743
Clin Chem. 2014 Jul;60(7):974-86
pubmed: 24829272
Biochem Med (Zagreb). 2015;25(1):73-83
pubmed: 25672470
Klin Onkol. 2015;28(4):273-7
pubmed: 26299741
J Am Soc Nephrol. 2016 Jul;27(7):2135-47
pubmed: 26701975
Eur Heart J. 2016 Oct 14;37(39):2999-3058
pubmed: 27567407
BMC Nephrol. 2017 Feb 2;18(1):47
pubmed: 28152985
Clin J Am Soc Nephrol. 2017 May 8;12(5):727-733
pubmed: 28377473
Biochem Med (Zagreb). 2017 Feb 15;27(1):153-176
pubmed: 28392738
J Physiol Pharmacol. 2017 Apr;68(2):175-180
pubmed: 28614766
Biochem Med (Zagreb). 2017 Oct 15;27(3):030502
pubmed: 29180913
Biochem Med (Zagreb). 2018 Feb 15;28(1):010701
pubmed: 29187794
Kidney Int Rep. 2018 Jun 02;3(5):1135-1143
pubmed: 30197980

Auteurs

Šálek Tomáš (Š)

Department of Clinical Biochemistry and Pharmacology, Tomas Bata Hospital, Zlín, Czech Republic.
Department of Biomedical Sciences, Medical Faculty of the University of Ostrava, Ostrava - Zábřeh, Czech Republic.
SEKK, spol. s.r.o., Pardubice, Czech Republic.

Friedecký Bedřich (F)

SEKK, spol. s.r.o., Pardubice, Czech Republic.

Kratochvíla Josef (K)

SEKK, spol. s.r.o., Pardubice, Czech Republic.

Pelinková Květa (P)

SEKK, spol. s.r.o., Pardubice, Czech Republic.
Institute of Medical Biochemistry and Laboratory Diagnostics, General University Hospital and The First Faculty of Medicine of Charles University in Prague, Prague, Czech Republic.

Budina Marek (B)

SEKK, spol. s.r.o., Pardubice, Czech Republic.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH